Species: Veillonella denticariosi (HMT-0887) Primary Body Site: Oral
Download Options
LINKS: Ecology Home
| HMT-0887: [Body Sites Data]
[Taxon Description]
| Life Page: Veillonella denticariosi
Hide Legend
Prev - Prevalence
10thp - 10th percentile
90thp - 90th percentile
ND - less than 0.001%
Body Site Legend:
| SUBP-- Subgingival Plaque |
| SUPP -- Supragingival Plaque |
| PERIO -- Periodontal |
| AKE -- Attached Keratinized Gingiva |
| BMU -- Buccal Mucosa |
| HPA -- Hard Palate |
| SAL -- Saliva |
| THR -- Throat |
| PTO -- Palatine Tonsils |
| TDO -- Tongue Dorsum |
| ANA -- Anterior Nares |
| LRC -- L_Retroauricular Crease |
| RRC -- R_Retroauricular Crease |
| LAF -- L_Antecubital Fossa |
| RAF -- R_Antecubital Fossa |
| VIN -- Vaginal Introitus |
| MVA -- Mid Vagina |
| PFO -- Posterior Fornix |
| STO -- Stool |
Prev - Prevalence
10thp - 10th percentile
90thp - 90th percentile
ND - less than 0.001%
Human Microbiome Project Mapping (Data from healthy subjects. - not published)
No Notes
| SUBP | SUPP | PERIO | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | LRC | RRC | RAF | VIN | MVA | PFO | STO | |
| Avg (%) | 0.07 | 0.06 | 0.05 | 0.05 | 0.04 | 0 | 0.03 | 0.02 | 0.02 | 0.02 | 0 | 0 | 0 | 0.01 | 0 | 0.01 | 0 | 0 |
| n | 24 | 395 | 24 | 15 | 323 | 1 | 8 | 7 | 22 | 423 | 65 | 23 | 30 | 1 | 4 | 8 | 94 | 375 |
| 10thp | 0.01 | 0.01 | 0 | 0 | 0 | 0 | 0.02 | 0.01 | 0 | 0.01 | 0 | 0 | 0 | 0.01 | 0 | 0 | 0 | 0 |
| 90thp | 0.14 | 0.14 | 0.13 | 0.07 | 0.09 | 0 | 0.04 | 0.03 | 0.03 | 0.03 | 0 | 0 | 0 | 0.01 | 0 | 0.02 | 0 | 0 |
| Stdev | 0.07 | 0.06 | 0.09 | 0.08 | 0.05 | 0 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0 | 0 | 0 | 0.03 | 0.01 | 0.01 |
| Prev(%) | 0 | 0.76 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.24 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Eren V1-V3 www.pnas.org
(Data from healthy subjects.)
No Notes
Eren V3-V5 www.pnas.org
(Data from healthy subjects.)
Notes:
Reads equally close to V. atypica, V. denticariosi, V. dispar, V. parvula, and V. rogosae were assigned one-fifth to each taxon.
Reads equally close to V. atypica, V. denticariosi, V. dispar, V. parvula, and V. rogosae were assigned one-fifth to each taxon.
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | STO | |
| Avg (%) | 0.80 | 0.75 | 0.28 | 0.57 | 1.17 | 2.32 | 1.55 | 1.41 | 2.01 | 0.01 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0.07 | 0.08 | 0 | 0.08 | 0.32 | 0.87 | 0.55 | 0.46 | 0.81 | 0 |
| 90thp | 2.05 | 1.71 | 0.78 | 1.40 | 2.31 | 3.92 | 2.69 | 2.61 | 3.27 | 0.01 |
| Stdev | 1.11 | 0.86 | 0.59 | 0.56 | 0.78 | 1.19 | 0.85 | 0.87 | 0.97 | 0.04 |
| Prev(%) | 98.65 | 100.00 | 91.22 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 29.37 |
Human Microbiome Project 16S RefSeq (V1-V3) (Data from healthy subjects. - not published)
No Notes
Human Microbiome Project 16S RefSeq (V3-V5) (Data from healthy subjects. - not published)
Notes:
Reads equidistant to HMT-161 and HMT-887 were assigned to each taxon in proportion to the abundance of HMT-161 and HMT-887 individually at this body site (SUBP).
Reads equidistant to HMT-161 and HMT-887 were assigned to each taxon in proportion to the abundance of HMT-161 and HMT-887 individually at this body site (SUBP).
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | LRC | RRC | LAF | RAF | VIN | MVA | PFO | STO | |
| Avg (%) | 0.02 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 0.02 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stdev | 0.15 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Prev(%) | 35.56 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Dewhirst 35x9 (35 Taxa by 9 Oral Sites. - not published)
Notes:
Reads equally close to HMT 160, 161, and 887 were assigned one-third to each taxon.
Reads equally close to HMT 160, 161, and 887 were assigned one-third to each taxon.
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | |
| Avg (%) | 0.02 | 0.03 | 0.01 | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 0.05 | 0.09 | 0.02 | 0.06 | 0.04 | 0.05 | 0.03 | 0.02 | 0.03 | 0 |
| Stdev | 0.04 | 0.04 | 0.01 | 0.03 | 0.04 | 0.02 | 0.01 | 0.01 | 0.02 | 0 |
| Prev(%) | 63.51 | 79.41 | 60.47 | 85.71 | 85.71 | 74.00 | 93.94 | 77.42 | 70.00 | 0 |
Human Microbiome Project Metaphlan (Data from healthy subjects. - not published)
No Notes
| SUBP | SUPP | PERIO | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | LRC | RRC | RAF | VIN | MVA | PFO | STO | |
| Avg (%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stdev | 0 | 0.02 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Prev(%) | 0 | 0.76 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
